Status:
COMPLETED
Stress Testing and Cardiac Magnetic Resonance
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Astellas Pharma Inc
Conditions:
Coronary Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to better define the role of a comprehensive stress MRI (which includes myocardial perfusion imaging, optimized coronary imaging, and myocardial scar imaging) in medical p...
Detailed Description
Coronary artery disease is a major cause of morbidity and mortality in the United States. Currently, the presence of physiologically significant coronary disease is most commonly diagnosed using non-i...
Eligibility Criteria
Inclusion
- Suspected coronary artery disease
- Symptoms of possible coronary artery disease
Exclusion
- Acute ST-elevation myocardial infarction
- Second or third degree AV block
- Severe Renal Disease (Glomerular Filtration Rate (GFR) \<30cc/min or hemodialysis)
- Contra-indications to MRI (i.e. Implantable Cardioverter Defibrillator (ICD), pacemaker, aneurysm clip, etc)
- Hemodynamic instability
- Inability to provide informed consent
- Severe claustrophobia
- Pregnancy
- Age \<18 years
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 4 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00871260
Start Date
April 1 2009
End Date
June 4 2014
Last Update
July 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637